Allarity Therapeutics, Inc. Financing Receivable, Percent Past Due
Allarity Therapeutics, Inc. (ALLR) had Financing Receivable, Percent Past Due of 35.00% as of 2024-01-01, per its 10-Q filed 2024-08-05.
Discontinued › Notes › and Others
us-gaap:FinancingReceivablePercentPastDue1 · last filed 2024-08-05
- 2024-01-01: Financing Receivable, Percent Past Due 35.00%.
- 2023-12-31: Financing Receivable, Percent Past Due 35.00%.
| Period end | Financing Receivable, Percent Past Due |
|---|---|
| 2024-01-01 | 35.00% 10-Q · filed 2024-08-05 |
| 2023-12-31 | 35.00% 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |